AAP 2011: ADHD Guidelines Updated for Diagnosis and Treatment in Children [Video]

Article

Mark Wolraich, MD, FAAP, lead author, discussed the updated ADHD guidelines which now include information on the diagnosis and treatment of children and adolescents.

Mark Wolraich, MD, FAAP, lead author, discussed the updated ADHD guidelines which now include information on the diagnosis and treatment of children and adolescents.

"The biggest change in the guidelines is that previously we really only felt comfortable that we had high enough level of evidence to make recommendations in children 6-12 year of age because that's where the bulk of the research on ADHD has been done."

"We also felt that we could expand the age into adolescent. It is not that we didn't think that pre-school students and adolescents in the previous guideline existed. It was just that we didn't feel that we had enough evidence to make recommendations," said Wolraich.

Related Videos
Thumbnail featuring Jay Luther, MD, Hersh Shroff, MD, MPA, and Chris Kahler, PhD
Thumbnail featuring Jay Luther, MD, Hersh Shroff, MD, MPA, and Chris Kahler, PhD
Advancing Brilaroxazine Research in Schizophrenia with Larry Ereshefsky, PharmD
Larry Ereshefsky, PharmD: Brilaroxazine Improves Schizophrenia Symptoms
Matthew Nudy, MD | Credit: Penn State Health
© 2024 MJH Life Sciences

All rights reserved.